Speaker

Philipp Tropberger

Senior Principal Scientist, Novartis AG

Philipp Tropberger, Senior Principal Scientist at Novartis AG, is speaking at 10th Antifibrotic Drug Development Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “Fireside Discussion: Celebrating 10 Years of Antifibrotic Drug Development: Reflecting on the Past to Shape the Next Decade”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

10th Antifibrotic Drug Development Summit 2026
1–3 Dec 2026Boston, United States of America
- PanelFireside Discussion: Celebrating 10 Years of Antifibrotic Drug Development: Reflecting on the Past to Shape the Next DecadeWith Marc Hertz
- SpeakerAchieving Cell-Selective Delivery to Maximize Efficacy & Minimize Systemic Toxicity

More speakers at 10th Antifibrotic Drug Development Summit 2026

Rebecca Taub
Director, Madrigal Pharmaceuticals
Bernard Allan
Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu, Takeda Pharmaceutical
Alexander Barron
Principal Scientist II, Novartis AG
Jeffrey Bornstein
CMO, Mediar Therapeutics
Victor Bustos
Co-Founder & Chief Executive Officer, Refoxy Pharmaceuticals
Steve De Vos
Head of Translational Sciences, Fibrocor Therapeutics

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Philipp Tropberger, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].